New PCa InfoLink

The New Prostate Cancer InfoLink is a daily news service providing information from Planet Prostate Cancer.

[New PCa InfoLink @NewPCaInfoLink]

Active surveillance: a future perspective https://t.co/zKj2Xw8wyJ

[New PCa InfoLink @NewPCaInfoLink]

NCCN guidance on initial management of low-risk, localized prostate cancer (redux) https://t.co/bJq23KpZSz

[New PCa InfoLink @NewPCaInfoLink]

Projected attendance at AS research conference https://t.co/Jx2RvDdEuu

[New PCa InfoLink @NewPCaInfoLink]

Registration for major active surveillance (AS) research conference now open https://t.co/h0tE8vxg5A

[New PCa InfoLink @NewPCaInfoLink]

NCCN guidance on the initial management of low-risk, localized prostate cancer https://t.co/tfAmDrfO5R

[New PCa InfoLink @NewPCaInfoLink]

Exceptions to “early salvage” radiation treatment forrecurrence after prostatectomy https://t.co/cRxzD1h12S

[New PCa InfoLink @NewPCaInfoLink]

Chances to hear from the new President and CEO of the Prostate Cancer Foundation https://t.co/wh99tiUKT9

[New PCa InfoLink @NewPCaInfoLink]

More than 25 organizations join new Prostate Cancer Impact Alliance https://t.co/aLtEAh1BDx

[New PCa InfoLink @NewPCaInfoLink]

Educational opportunities on September 29 upcoming https://t.co/qeYmvvoWs5

[New PCa InfoLink @NewPCaInfoLink]

Whole-pelvic radiation therapy for high-risk patients https://t.co/lKr4FnvhHk

[New PCa InfoLink @NewPCaInfoLink]

Fear of prostate cancer recurrence post-surgery https://t.co/5AsaOhZ5jZ

[New PCa InfoLink @NewPCaInfoLink]

Timing of initiation of ADT for men with biochemical progression after first-line surgery https://t.co/4Hc9AtWPUb

[New PCa InfoLink @NewPCaInfoLink]

Rethinking risk stratification for radiation therapy https://t.co/eGRmqFfsie

[New PCa InfoLink @NewPCaInfoLink]

Helpful upcoming webinars this week https://t.co/mIGyPwadAS

[New PCa InfoLink @NewPCaInfoLink]

AS research survey: your help still needed https://t.co/Qs8VisYocG

[New PCa InfoLink @NewPCaInfoLink]

Three helpful upcoming webinars https://t.co/djnlCgmDHt

[New PCa InfoLink @NewPCaInfoLink]

Research on AS in management of prostate cancer: your input is important! https://t.co/O1xeBSEHsN

[New PCa InfoLink @NewPCaInfoLink]

Extending OS on initial ADT for men with mHSPC https://t.co/b89hwWN4Ab

[New PCa InfoLink @NewPCaInfoLink]

Lower salvage radiation dose — are outcomes the same? https://t.co/OLK41DguGR

[New PCa InfoLink @NewPCaInfoLink]

Brief, intense radiation and hormone therapy for very high-risk prostate cancer https://t.co/b6wdS2oPGS